Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. company information, Employees & Contact Information

Explore related pages

Oramed Pharmaceuticals Inc. email format Oramed Pharmaceuticals Inc. management contacts

Related company profiles:

Oramed Pharmaceuticals (NASDAQ:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in Phase 3 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes. Watch: https://www.youtube.com/watch?v=5qChxTDV9eg Terms and conditions and privacy policy: https://www.oramed.com/web-site-terms-and-conditions/

Company Details

Employees
16
Founded
-
Address
20 Mamilla Avenue, 3rd Floor,israel
Phone
97225660001
Email
ir****@****med.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
http://www.oramed.com
Keywords
Oral insulin, Pharmaceuticals, GLP-1, Diabetes, Diabetes Type 1, Diabetes Type 2, Insulin, Insulin Research, Diabetes Research, biotech.
HQ
Jerusalem
Competitors
BioLineRx, MeMed, KAMADA, Protalix Biotherapeutics, Alpha Tau Medical, Pluri, IATI - Israel Advanced Technology Industries Association, Dexcel Pharma, BrainsWay, Oravax Medical.
Looking for a particular Oramed Pharmaceuticals Inc. employee's phone or email?

Oramed Pharmaceuticals Inc. Questions

News

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives - Morningstar

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives Morningstar

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - PR Newswire

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical PR Newswire

Oramed Shareholders to Receive Double Dividend: Cash Payment Plus OraTech Nasdaq Listing Shares - Stock Titan

Oramed Shareholders to Receive Double Dividend: Cash Payment Plus OraTech Nasdaq Listing Shares Stock Titan

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - PR Newswire

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin PR Newswire

Oramed Letter to Shareholders - PR Newswire

Oramed Letter to Shareholders PR Newswire

Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes - PR Newswire

Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes PR Newswire

Oramed Announces Oravax's Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial - PR Newswire

Oramed Announces Oravax's Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial PR Newswire

Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes - PR Newswire

Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes PR Newswire

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PR Newswire

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt PR Newswire

Oramed Letter to Shareholders - PR Newswire

Oramed Letter to Shareholders PR Newswire

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China - PR Newswire

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China PR Newswire

Oramed Issues Annual Message to Shareholders - PR Newswire

Oramed Issues Annual Message to Shareholders PR Newswire

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company - PR Newswire

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company PR Newswire

Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine - PR Newswire

Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine PR Newswire

Oramed Appoints Ben Shapiro to its Board of Directors - PR Newswire

Oramed Appoints Ben Shapiro to its Board of Directors PR Newswire

Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa - PR Newswire

Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa PR Newswire

Oramed Appoints Yadin Rozov to its Board of Directors - PR Newswire

Oramed Appoints Yadin Rozov to its Board of Directors PR Newswire

Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America - PR Newswire

Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America PR Newswire

Oramed (NASDAQ: ORMP) posts $210M assets, plans one-time dividend; U.S. insulin trial - Stock Titan

Oramed (NASDAQ: ORMP) posts $210M assets, plans one-time dividend; U.S. insulin trial Stock Titan

Oramed Appoints Ben Shapiro to its Board of Directors - citybiz

Oramed Appoints Ben Shapiro to its Board of Directors citybiz

Oramed Pharmaceuticals Appoints Netanel Derovan Chief Legal Officer - citybiz

Oramed Pharmaceuticals Appoints Netanel Derovan Chief Legal Officer citybiz

Oramed Appoints Yadin Rozov to its Board of Directors - citybiz

Oramed Appoints Yadin Rozov to its Board of Directors citybiz

Oramed to Present at the Diabetes Technology Meeting - PR Newswire

Oramed to Present at the Diabetes Technology Meeting PR Newswire

Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules - BioSpace

Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules BioSpace

Companies like Oramed Pharmaceuticals Inc.

Alpha Tau Medical logo - Similar company to Oramed Pharmaceuticals Inc.

Alpha Tau Medical

103
Oravax Medical logo - Similar company to Oramed Pharmaceuticals Inc.

Oravax Medical

NA
BioLineRx logo - Similar company to Oramed Pharmaceuticals Inc.

Biolinerx

54
IATI - Israel Advanced Technology Industries Association logo - Similar company to Oramed Pharmaceuticals Inc.

Iati - Israel Advanc...

29
Dexcel Pharma logo - Similar company to Oramed Pharmaceuticals Inc.

Dexcel Pharma

520
Pluri logo - Similar company to Oramed Pharmaceuticals Inc.

Pluri

254
Protalix Biotherapeutics logo - Similar company to Oramed Pharmaceuticals Inc.

Protalix Biotherapeu...

192
KAMADA logo - Similar company to Oramed Pharmaceuticals Inc.

Kamada

335
MeMed logo - Similar company to Oramed Pharmaceuticals Inc.

Memed

107
BrainsWay logo - Similar company to Oramed Pharmaceuticals Inc.

Brainsway

136

Top Oramed Pharmaceuticals Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant